Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded in controlling the infection in a ...

Engineered CAR‑T cells suppressed HIV off medication in two people — promising but early. Larger trials are needed.

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs.

Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...

Scientists are testing CAR-T cell therapy to help people living with HIV stay healthy without daily medication. Two patients ...

Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...

Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. We might be a step closer to curing HIV, as researchers have developed ...

Authorities urged patients to get tested due to "poor infection control practices" at the Australian clinic.

Patients who have been "functionally cured" of HIV underwent incredibly risky procedures. For most people, though, HIV is no ...

Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...